James River Group Holdings, Ltd. Overview
James River Group Holdings is a U.S.-focused specialty property-casualty insurer. It has shrunk deliberately from a three-segment, Bermuda-domiciled group into a small-cap excess and surplus (E&S) casualty specialist headquartered in North Carolina. Its franchise is the E&S segment, led by James River Insurance Company and James River Casualty Company. The segment wrote $963.0M of gross premium in 2025 (≈0.7% of a $143.3B U.S. surplus lines market), concentrated in small and middle-market general liability, excess casualty, manufacturers and contractors, and niche classes. It distributes exclusively through wholesale brokers. A shrinking Specialty Admitted segment (Falls Lake/Stonewood) provides fronting capacity for fees. Between 2023 and 2025, management sold the reinsurance arm, ring-fenced 2010–2023 E&S reserves with two retroactive covers, took on Enstar and Gallatin Point as anchor investors, and redomesticated to Delaware. The equity trades at roughly 0.4x tangible book because of persistent doubts over legacy reserves and earnings durability.
Company's own description
The company describes itself, in its earnings releases and 10-K FY2025, as a holding company that owns and operates a group of specialty insurance companies. It operates in two specialty property-casualty insurance segments, Excess and Surplus Lines and Specialty Admitted Insurance, each of whose regulated subsidiaries is rated "A-" by AM Best. Its investor-relations site further characterizes the business as focused on underwriting small and middle-market casualty risks within the U.S. E&S market.
The 3Q 2025 investor presentation lists the company's key investment highlights:
-
a focus on profitable growth in the small-to-medium enterprise E&S market;
-
a "reinvigorated underwriting culture";
-
a 20-plus-year wholesale-only distribution model;
-
reinsurance and legacy protection for 2023 and prior accident years;
-
a refreshed management team;
-
expense efficiencies, including from the U.S. redomicile.
Business model and revenue model
James River earns revenue from four sources:
-
Net earned premiums. $600.3M in FY2025, 87.3% of total revenues of $687.6M. This is the core risk-bearing insurance revenue, essentially all from E&S ($559.5M) after the deliberate run-down of retained Specialty Admitted premium ($40.8M).
-
Net investment income. $83.4M in FY2025, 12.1% of revenue. It is earned on a $1.70B invested portfolio, mostly investment-grade fixed maturities, plus bank loans, equities and private investments. The annualized gross yield was 4.6% in Q4 2025 and Q2 2026.
-
Fee income. Gross fee income of $13.4M in FY2025, versus $21.0M in FY2024 and $24.2M in FY2023. It comes from fronting arrangements in Specialty Admitted, where the company issues admitted policies for program administrators and MGAs and cedes most of the risk to reinsurers.
-
Realized/unrealized investment gains and other income. Net losses of $2.2M and other income of $6.1M in FY2025.
In the requested product/service/subscription/licensing framework, the company is a pure "risk-transfer service" provider. There is no product, subscription or licensing revenue. Fronting fees are the only fee-for-service component, and they are declining by management choice.
Value-chain position
James River sits at the carrier/risk-bearer layer of the commercial P&C chain:
Retail agents: place business with wholesale brokers / MGAs. The company is wholesale-only in E&S and uses program administrators in Specialty Admitted.
James River: writes the policy as a non-admitted (E&S) or admitted (Falls Lake) carrier.
Reinsurers: absorb ceded risk. Group premium retention was only 55% in Q2 2026 (47% in Q2 2025), so reinsurance is a structurally large share of the model.
Legacy/run-off counterparties: (State National Insurance Company, Enstar/Cavello Bay) hold retroactive covers on 2010–2023 E&S reserves.
Customer types and end-markets
The end customers are U.S. small and middle-market commercial insureds whose risks are hard to place with standard admitted carriers:
-
manufacturers and contractors;
-
general casualty classes;
-
excess casualty buyers;
-
energy operators;
-
life-sciences companies;
-
allied-healthcare and social-service providers;
-
environmental contractors;
-
small businesses;
-
management-liability buyers;
-
historically, excess property and commercial auto.
Management is pivoting toward smaller insureds. The average E&S premium per policy fell 10% in 2025 (Q4 2025 release), and average account premium fell 22.9% year over year in Q2 2026 (Q2 2026 call summary). Direct "customers" in the commercial sense are the wholesale brokers and program partners. The 10-K risk factors flag reliance on a select group of brokers and agents.
Independent characterization
Economically, James River today is a sub-scale, casualty-heavy E&S writer in turnaround. Its reported combined ratios have normalized into the mid-to-high 90s on business not subject to retroactive accounting (96.6% in FY2025). However, GAAP earnings remain volatile because of three factors:
-
retroactive reinsurance accounting, which added 4.8 points to the FY2025 consolidated combined ratio and 7.7 points in 1H 2026;
-
legacy reinsurance-treaty reinstatement premiums ($6.7M in Q1 2026 from a 2022 treaty);
-
a thin capital cushion relative to $3.09B of gross loss reserves.
The equity story is now about whether recent accident years (2024 onward, written after major underwriting changes) are adequately reserved. It also depends on whether the company can grow net written premium in a softening E&S market without repeating the 2015–2022 casualty reserve problems.
Strategy
Stated strategy themes
From the 10-K FY2025, the Q4 2025 and Q2 2026 releases, and the 3Q 2025 investor presentation:
-
E&S focus on small and medium enterprises. Pursue "compelling opportunities across the E&S market" (CEO, Mar 2026) with emphasis on smaller, profitable accounts. Average premium per policy fell 10% in 2025.
-
Underwriting discipline and cautious risk selection. Primary focus on cautious risk selection, expense management, and operating efficiency enabled by innovation (CEO, Q2 2026). Rates are being adjusted ahead of loss trend in some classes and relaxed in others to gain scale (Q4 2025 call).
-
Legacy-risk containment. The E&S ADC and E&S Top Up ADC cover E&S accident years 2010–2023, excluding excess property and the run-off Uber portfolio. Treaty placements were restructured in July 2023.
-
Expense efficiency. G&A fell 9% in 2025 and 9% in 1H 2026. The redomicile is described as producing a permanent expense-ratio reduction of more than 1 point (Q4 2025 call summary). The effective tax rate is expected to move toward the U.S. statutory rate.
-
Capital reallocation from fronting to E&S. Deliberate reduction of Specialty Admitted fronting raised group premium retention to 55% (Q2 2026).
-
Wholesale-only distribution. A 20-plus-year model positioned as a source of broker loyalty (investor presentation).
Strategic initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Detail / target | Status |
|---|---|---|---|
| Enstar strategic partnership | Nov 11, 2024 | $12.5M equity at $6.40; $75M E&S Top Up ADC | Closed Dec 23, 2024; ADC limit fully utilized by Q2 2026 |
| Series A preferred amendment | Nov 11, 2024 | $37.5M converted to common at $6.40; 7% dividend fixed for five years after Sep 30, 2024, then reset (5-year Treasury + 5.2%, capped at 8%) | Complete |
| E&S leadership reorganization | May–Oct 2025 | Sutherland promoted; Schmitzer retired | Complete |
| Technology/claims leadership refresh | Jul 2025 | New Group CIO and Group Chief Claims Officer | Complete |
| Redomicile to Delaware | Nov 7, 2025 | Tax efficiency; $14.1M one-time benefit | Complete |
| Expense program | 2025–2026 | Headcount reductions; G&A -9% in 2025 and -9% in 1H 2026 | Ongoing; no numeric multi-year target disclosed |
| Excess Casualty rebuild | Mar 4, 2026 | Kelly Hadiaris recruited to lead Excess Casualty | Ongoing |
| Specialty Admitted fronting reduction | 2025–2026 | Segment GWP -49.5% (2025), -76% (Q2 2026) | Ongoing |
| Investment repositioning | 2H 2025 – 2026 | Added "A"-rated structured securities; shifted private holdings from concentrated equity to rated notes; defensive bank-loan rebalancing after spring 2025 tariff announcements | Ongoing |
ESG/sustainability commitments: none publicly quantified.
Medium-term financial targets: not publicly disclosed. The company does not issue numeric guidance. Internal 2025 targets disclosed in the proxy were a group adjusted combined ratio of 96.2%, E&S 89.5%, and adjusted EBIT of $108.4M. PRSU metrics are adjusted operating return on tangible common equity and tangible book value per share growth; 2023–2025 targets were 12.9% and 8.2% annualized respectively.
Products & Services
Disclosure note: Division-level premium was last disclosed in the 10-K FY2021, which reported 13 E&S divisions. More recent 10-Ks discuss divisions qualitatively. Management commentary on the Q4 2025 call indicated Property GWP fell 27% and Manufacturers & Contractors fell 11% in 2025. Pricing is risk-rated and individually underwritten; no list pricing is disclosed. Launch years for individual divisions are not publicly disclosed except where noted.
E&S division premium
| E&S division GWP (USD Mn) | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
| Excess Casualty | 119.0 | 213.0 | 285.1 |
| General Casualty | 115.8 | 125.4 | 140.6 |
| Manufacturers and Contractors | 105.1 | 122.9 | 139.7 |
| Excess Property | 31.6 | 37.3 | 47.2 |
| Energy | 45.4 | 51.1 | 46.2 |
| Life Sciences | 24.5 | 35.2 | 35.9 |
| Allied Health | 26.7 | 26.9 | 35.2 |
| Small Business | 19.7 | 24.8 | 32.6 |
| Environmental | 16.5 | 17.8 | 17.1 |
Source: 10-K FY2021 and FY2020. Remaining divisions (e.g., Professional/Management Liability, Commercial Auto run-off, others) were not captured in the excerpt reviewed.
E&S segment (James River Insurance Company / James River Casualty Company)
-
Excess Casualty. Excess and umbrella liability above primary GL for manufacturers, contractors, distributors and (historically) transportation risks (10-K FY2014–2016 descriptions). Target: middle-market commercial insureds needing excess limits. It was the largest division by 2021 ($285.1M). The company hired Kelly Hadiaris (Mar 4, 2026) to lead Excess Casualty, signalling renewed emphasis. On the Q1 2026 call, management said excess casualty underwriters industry-wide were showing "more respect for loss trend."
-
General Casualty. Primary general liability for a broad range of non-standard commercial classes. FY2021 GWP $140.6M. Much of the 2015–2020 primary-GL accident-year development came from this book; Q4 2023 reserve charges related to accident years 2015–2020 primary GL.
-
Manufacturers and Contractors (M&C). Primary GL for manufacturers of consumer, commercial and industrial products and for general and trade contractors (10-K FY2015). FY2021 GWP $139.7M; GWP down 11% in 2025 on appetite tightening.
-
Excess Property. Commercial property capacity in the E&S market. FY2021 GWP $47.2M; GWP down 27% in 2025. It is excluded from the E&S ADC/Top Up coverage, so it remains net exposure (Q1 2026 call).
-
Energy. Liability for businesses engaged in energy production, distribution or mining, and manufacturers of equipment used in energy (10-K FY2015). FY2021 GWP $46.2M.
-
Life Sciences. GL, products and/or professional liability for manufacturers, distributors and developers of biologics, nutraceuticals, human clinical trials, pharmaceuticals (mainly generics/OTC) and medical devices (10-K FY2015). FY2021 GWP $35.9M.
-
Allied Health. Casualty for allied-health and social-service risks such as long-term care facilities, group homes, shelters, drug rehabilitation, home health care and medical staffing. Historically ~95% written on a claims-made-and-reported form (10-K FY2016). FY2021 GWP $35.2M.
-
Small Business. Accounts with annual primary liability premium below $10,000. Coverage and pricing flexibility is limited to enable quick turnaround, and applications are submitted through an internet portal (10-K FY2014–2016). FY2021 GWP $32.6M. It is strategically aligned with the current "smaller insureds" pivot.
-
Environmental. Occurrence-form environmental liability for contractors not engaged in remediation work (10-K FY2014). FY2021 GWP $17.1M.
-
Management Liability / Professional Liability. Todd Sutherland joined in April 2023 as SVP Underwriting, Management Liability, before becoming E&S President (10-K/A FY2025). Premium not disclosed.
-
Commercial Auto (run-off). Former large-insured book (Rasier/Uber affiliates), in run-off under the July 2021 Commercial Auto LPT. Claims are handled by a third-party administrator funded from collateral in a trust: restricted cash of $8.6M at Jun 30, 2026 (Q2 2026 release). This book is excluded from the E&S ADCs and covered by its own legacy structure.
Specialty Admitted segment (Falls Lake National / Stonewood / Falls Lake Fire & Casualty)
-
Fronting and program business. Admitted policy issuance for MGAs and program administrators, with most risk ceded to reinsurers. The company retains fee income and a minority share of net premium. FY2023 fronting/program GWP grew 12.5% in Q4 2023 excluding a non-renewed California workers' compensation program. It is now being deliberately reduced: Q2 2026 segment GWP was $18.7M (-76%), and NWP was only $0.7M.
-
Individual-risk workers' compensation (Stonewood). Renewal rights sold in 2023. The related IRWC trademark intangible was impaired by $2.5M in 2023 (Q4 2023 release). The book is now in run-off.
Former segment (discontinued)
Casualty Reinsurance (JRG Re, Bermuda): Proportional and excess casualty treaty reinsurance for U.S. specialty insurers. FY2021 GWP $182.1M (10-K FY2021). Placed into run-off in 2022 and sold to Fleming in April 2024.
Financial Narrative
Basis: Continuing operations (ex-JRG Re) as restated in later filings, unless labeled.
-
FY2022–FY2025 income-statement data: Q4 2023 and Q4 2025 releases.
-
FY2021 restated figures: edgar.tools/TipRanks extraction of 10-K data, flagged where used.
-
Balance-sheet data for FY2022–FY2023 include JRG Re as held-for-sale assets and liabilities.
-
Blank cells mean the figure is not available on a comparable basis in the sources reviewed.
Insurance-specific note: Gross profit, EBITDA, working capital, current ratio and cash conversion cycle are not meaningful for a P&C insurer and are not reported by the company. Insurance-appropriate substitutes are provided: underwriting profit, EBIT proxy, combined ratio, and debt-to-capital.
Income statement
Notes: - FY2021 NWP, NEP, NII, gains, opex and continuing net income are rounded restated figures from the 10-K multi-year data (edgar.tools). FY2021 revenue of 609.0 is from TipRanks and is consistent with the restated basis.
-
FY2021 DPS assumes four $0.30 quarterly payments. Jun and Sep 2021 payments of $0.30 are confirmed by dividend-history records; the cut to $0.05 began Mar 2022.
-
FY2024 preferred dividends include a $27.0M deemed dividend from the Nov 2024 Series A amendment.
-
FY2025 tax includes a one-time $14.1M benefit from the redomicile.
Margins and growth (%)
Revenue CAGR:
-
FY2021–FY2025: (687.6/609.0)^(1/4) − 1 ≈ 3.1%
-
FY2022–FY2025: ≈ 1.3%
-
Net earned premium FY2021–FY2025: ≈ 1.7% (561 → 600.3)
Balance sheet
Short- versus long-term debt split: all debt is long-term. Senior debt is a bank credit facility; junior subordinated debentures are trust-preferred structures (James River Capital Trusts I–IV and Franklin Holdings II (Bermuda) Capital Trust I per Exhibit 21). No debt is classified as current in the releases reviewed. Working capital is not applicable to insurers.
Cash flow
Sources: - 10-K FY2023, FY2024 and FY2025 liquidity sections for operating cash flow excluding restricted cash.
-
StockAnalysis and Barchart (derived from 10-K cash-flow statements) for reported OCF, investing, financing, capex, issuance and repayment.
-
2021 operating outflow reflects funding of the Commercial Auto LPT.
-
2024 outflow reflects $313.2M and $52.8M of reinsurance premium paid for the E&S ADC and the E&S Top Up ADC respectively (10-K FY2025 cash-flow note).
Ratios
Methodology: - FY2022 ROE and ROA use year-end balances because FY2021 restated balances were unavailable.
-
ROIC uses continuing net income plus interest × (1 − 21%), divided by year-end capital.
-
Current ratio, net debt/EBITDA and cash conversion cycle are not applicable to insurers.
Trend commentary
Revenue. The top line is essentially flat over five years once the reinsurance segment is excluded, but its composition changed sharply:
-
Gross written premium peaked at $1.51B in 2023 and fell 22% to $1.17B in 2025, driven by the deliberate collapse of Specialty Admitted fronting (-58% from 2023 to 2025) and a 5% E&S decline in 2025.
-
Net premium is far less volatile because fronting is mostly ceded.
-
Net investment income nearly doubled from 2022 to 2023 ($43.2M to $84.0M) on higher yields, peaked at $93.1M in 2024, then eased to $83.4M as rates fell and cash was used for ADC premiums.
Underwriting. The inflection points are 2023–2024. Q4 2023 added $25.0M of E&S adverse development (accident years 2015–2020 primary GL). In 2024, large reserve strengthening and the $52.8M Top Up ADC premium drove a 117.6% combined ratio. By 2025, with legacy volatility pushed into retroactive covers (4.8 points of retroactive charges sit outside the headline ratio), the combined ratio normalized to 96.6%. The E&S accident-year loss ratio has been stable at 63.5–64.9% since 2024.
Expenses. The expense ratio rose from 23.6% (2022) to 30–31% (2024–2025) because lower ceding commissions, the ADC premium charged against earned premium, and fronting run-off reduced fee offsets. Absolute G&A is falling: -9% in 2025 and -9% in 1H 2026.
Capital. Tangible common equity per share fell from $9.51 (2022) to $6.67 (2024), was rebuilt to $8.94 (2025) and stood at $9.01 in Q2 2026. Equity is propped up by the $133M Series A preferred, a recognized $107.8M deferred retroactive gain (a non-cash future earnings stream), and $214M of goodwill/intangibles; the last is roughly 41% of shareholders' equity.
Leverage. Debt-to-capital has been stable at roughly 32–34%, but interest coverage of about 3x is thin for a sub-$1B-capital specialty insurer.
Cash flow. Operating cash flow has been dominated by reinsurance transactions (the 2021 LPT and the 2024 ADCs) rather than underwriting. Underlying operating cash generation is modest at present, which is consistent with shrinking net premium.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Legal entities (Exhibit 21 / AM Best) | What it contains |
|---|---|---|
Excess and Surplus Lines (E&S) | James River Insurance Company (Ohio); James River Casualty Company (Virginia) | Non-admitted commercial casualty (primary GL, excess casualty, products, professional/management liability), limited excess property, small business; run-off commercial auto (Rasier) under LPT |
Specialty Admitted Insurance | Falls Lake National Insurance Company (Ohio); Stonewood Insurance Company (North Carolina); Falls Lake Fire and Casualty Company (California) | Fronting and program business (admitted paper for MGAs/program administrators, mostly reinsured); legacy individual-risk workers' compensation (renewal rights sold 2023) |
Corporate and Other | Holding company, James River Group, Inc. (Delaware), James River Management Company, capital trusts | Holding-company expenses, debt, investments not allocated |
Former: Casualty Reinsurance | JRG Reinsurance Company Ltd. (Bermuda) | Sold Apr 16, 2024; discontinued operations for all periods |
Revenue by Segment
| Segment metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
E&S gross written premium (USD Mn) | 921.2 | 1,007.4 | 1,017.0 | 963.0 |
Specialty Admitted gross written premium (USD Mn) | 490.2 | 501.3 | 414.7 | 209.3 |
Total gross written premium (USD Mn) | 1,411.4 | 1,508.7 | 1,431.8 | 1,172.3 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment — E&S net earned premium
| Segment metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
E&S net earned premium (USD Mn) | 555.6 | 609.6 | 512.2 | 559.5 |
Specialty Admitted net earned premium (USD Mn) | 74.1 | 98.4 | 88.0 | 40.8 |
Total net earned premium (USD Mn) | 629.7 | 708.0 | 600.2 | 600.3 |
Results by Segment
| Segment metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
E&S underwriting profit (USD Mn) | 83.1 | 54.3 | -77.5 | 59.5 |
Specialty Admitted underwriting profit (USD Mn) | 4.2 | 4.1 | 6.9 | -5.7 |
Corporate & Other operating expenses (USD Mn) | -31.3 | -33.9 | -35.0 | -33.5 |
Consolidated underwriting profit (USD Mn) | 56.0 | 24.5 | -105.6 | 20.3 |
Revenue by Segment (%) and Results by Segment
| Segment metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
E&S combined ratio (%) | 85.1 | 91.1 | 115.1 | 89.4 |
E&S loss ratio (%) | 65.9 | 68.9 | 87.6 | 64.0 |
E&S expense ratio (%) | 19.2 | 22.2 | 27.5 | 25.4 |
E&S accident-year loss ratio (%) | 66.0 | 61.9 | 64.3 | 63.5 |
Specialty Admitted combined ratio (%) | 94.3 | 95.9 | — | — |
Specialty Admitted gross fee income (USD Mn) | 23.6 | 24.2 | 21.0 | 13.4 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
E&S GWP YoY growth (%) | 9.4 | 1.0 | -5.3 |
Specialty Admitted GWP YoY growth (%) | 2.3 | -17.3 | -49.5 |
E&S share of total GWP (%) | 66.8 | 71.0 | 82.1 |
E&S share of total NEP (%) | 86.1 | 85.3 | 93.2 |
Specialty Admitted share of total NEP (%) | 13.9 | 14.7 | 6.8 |
Revenue by Segment and Revenue by Segment (%)
| Metric | 1H 2025 | 1H 2026 |
|---|---|---|
E&S GWP (USD Mn) | 513.7 | 462.5 |
Specialty Admitted GWP (USD Mn) | 158.7 | 42.8 |
E&S NEP (USD Mn) | 278.4 | 269.1 |
Specialty Admitted NEP (USD Mn) | 26.1 | 5.6 |
E&S underwriting profit (USD Mn) | 23.4 | 14.6 |
Specialty Admitted underwriting loss (USD Mn) | -1.7 | -4.6 |
E&S combined ratio (%) | 91.6 | 94.6 |
Consolidated combined ratio (%) | 99.1 | 102.4 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross written premiums (USD Mn) | — | 1,411.4 | 1,508.7 | 1,431.8 | 1,172.3 |
Net written premiums (USD Mn) | 585 | 665.4 | 693.9 | 580.9 | 568.8 |
Net earned premiums (USD Mn) | 561 | 629.7 | 708.0 | 600.2 | 600.3 |
Net investment income (USD Mn) | 32 | 43.2 | 84.0 | 93.1 | 83.4 |
Net realized/unrealized investment gains (USD Mn) | 11 | -15.7 | 10.4 | 3.6 | -2.2 |
Total revenues (USD Mn) | 609.0 | 661.5 | 812.0 | 707.6 | 687.6 |
Losses and LAE (USD Mn) | — | 440.6 | 500.2 | 554.4 | 427.2 |
Other operating expenses (USD Mn) | 133 | 152.6 | 193.7 | 193.2 | 184.0 |
Interest expense (USD Mn) | — | 13.9 | 24.6 | 24.7 | 23.5 |
Underwriting profit, non-GAAP (USD Mn) | — | 56.0 | 24.5 | -105.6 | 20.3 |
EBIT proxy: pre-tax income + interest (USD Mn) | — | 67.1 | 111.5 | -46.5 | 74.1 |
Pre-tax income, continuing (USD Mn) | — | 53.3 | 86.9 | -71.1 | 50.5 |
Income tax expense (benefit) (USD Mn) | — | 18.4 | 25.7 | -7.6 | 0.7 |
Net income, continuing (USD Mn) | -85 | 34.9 | 61.2 | -63.5 | 49.8 |
Net loss, discontinued (USD Mn) | — | -3.9 | -168.9 | -17.6 | -2.4 |
Net income (loss), total (USD Mn) | -172.8 | 31.0 | -107.7 | -81.1 | 47.4 |
Preferred dividends incl. deemed (USD Mn) | 0 | 8.8 | 10.5 | 37.1 | 7.9 |
Net income to common (USD Mn) | -172.8 | 22.2 | -118.2 | -118.3 | 39.6 |
Adjusted net operating income, non-GAAP (USD Mn) | — | 51.7 | 50.3 | -41.5 | 54.1 |
EPS basic, total (USD) | — | 0.59 | -3.14 | -3.06 | 0.86 |
EPS diluted, total (USD) | — | 0.59 | -3.13 | -3.06 | 0.79 |
EPS diluted, continuing (USD) | — | 0.69 | 1.34 | -2.60 | 0.83 |
Adjusted operating EPS diluted (USD) | — | 1.37 | 1.33 | -1.07 | 1.03 |
Dividends per share (USD) | 1.20 | 0.20 | 0.20 | 0.16 | 0.04 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Loss ratio (%) | — | 67.5 | 69.9 | 86.2 | 66.4 |
Expense ratio (%) | — | 23.6 | 26.6 | 31.4 | 30.2 |
Combined ratio, ex-retroactive (%) | — | 91.1 | 96.5 | 117.6 | 96.6 |
Combined ratio incl. retroactive reinsurance (%) | — | 93.6 | 97.2 | 123.8 | 101.4 |
Accident-year loss ratio (%) | — | 68.2 | 64.0 | 66.2 | 65.3 |
Underwriting margin, 100 minus CR (%) | — | 8.9 | 3.5 | -17.6 | 3.4 |
Pre-tax margin, continuing (%) | — | 8.1 | 10.7 | -10.1 | 7.4 |
Net margin, total net income / revenue (%) | -28.4 | 4.7 | -13.3 | -11.5 | 6.9 |
Total revenue YoY growth (%) | — | 8.6 | 22.8 | -12.9 | -2.8 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (USD Mn) | — | 5,137.1 | 5,317.3 | 5,007.1 | 4,859.9 |
Total invested assets (USD Mn) | — | 1,463.5 | 1,705.9 | 1,552.4 | 1,697.2 |
Cash and equivalents (USD Mn) | 190 | 159.2 | 274.3 | 362.3 | 260.9 |
Restricted cash equivalents (USD Mn) | 102 | 103.2 | 72.4 | 28.7 | 8.5 |
Reinsurance recoverable on unpaid losses (USD Mn) | — | 1,259.6 | 1,358.5 | 1,996.9 | 2,026.1 |
Reserve for losses and LAE (USD Mn) | — | 2,341.0 | 2,606.1 | 3,084.4 | 3,099.4 |
Senior debt (USD Mn) | — | 222.3 | 222.3 | 200.8 | 225.8 |
Junior subordinated debt (USD Mn) | — | 104.1 | 104.1 | 104.1 | 104.1 |
Total debt (USD Mn) | — | 326.4 | 326.4 | 304.9 | 329.9 |
Net debt, consolidated cash basis (USD Mn) | — | 167.2 | 52.1 | -57.4 | 69.0 |
Series A redeemable preferred, mezzanine (USD Mn) | — | 144.9 | 144.9 | 133.1 | 133.1 |
Shareholders' equity (USD Mn) | — | 553.8 | 534.6 | 460.9 | 538.2 |
Goodwill and intangibles (USD Mn) | — | 217.5 | 214.6 | 214.3 | 213.9 |
Deferred retroactive reinsurance gain (USD Mn) | — | 15.7 | 20.7 | 58.0 | 86.7 |
Tangible common equity, non-GAAP (USD Mn) | — | 356.4 | 340.7 | 304.6 | 411.0 |
Book value per share (USD) | — | 14.78 | 14.20 | 10.10 | 11.71 |
Tangible common equity per share (USD) | — | 9.51 | 9.05 | 6.67 | 8.94 |
Common shares outstanding (M) | — | 37.47 | 37.64 | 45.64 | 45.97 |
Financial Analysis
| Item | Value |
|---|---|
Total assets | $4,773.1M |
Cash | $195.6M |
Invested assets | $1,743.6M |
Gross loss reserves | $3,090.0M |
Reinsurance recoverable on unpaid losses | $2,032.0M |
Total debt | $329.9M |
Shareholders' equity | $522.6M (book value per share $11.30) |
Tangible common equity | $416.7M ($9.01/share) |
Deferred reinsurance gain | $107.8M |
Accumulated other comprehensive loss | $44.9M |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow, reported (USD Mn) | -913.5 | 222.7 | 88.0 | -247.1 | -18.8 |
Operating cash flow excl. restricted cash (USD Mn) | -155.6 | 221.5 | 118.7 | -203.3 | 1.4 |
Operating cash flow, continuing, excl. restricted cash (USD Mn) | -134.4 | 246.6 | 234.6 | -178.2 | — |
Capital expenditure, derived (USD Mn) | 6.3 | 8.2 | 6.4 | 4.9 | 4.8 |
Free cash flow, OCF reported less capex (USD Mn) | -919.8 | 214.5 | 81.5 | -252.0 | -23.6 |
Investing cash flow (USD Mn) | 35.8 | -328.2 | 16.7 | 307.0 | -116.0 |
Financing cash flow (USD Mn) | 147.7 | 89.7 | -21.1 | -28.8 | 13.2 |
Common dividends declared, derived DPS × basic shares (USD Mn) | — | 7.5 | 7.5 | 6.2 | 1.8 |
Share buybacks (USD Mn) | 0 | 0 | 0 | 0 | 0 |
Common equity issued (USD Mn) | 194.0 | 0 | 0 | 12.5 | 0 |
Preferred equity issued (USD Mn) | 0 | 144.9 | 0 | 0 | 0 |
Net debt issued (repaid) (USD Mn) | 0 | -40.0 | 0 | -21.5 | 25.0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
ROE, net income to common / average equity (%) | 4.0 | -21.7 | -23.8 | 7.9 |
Adjusted net operating return on tangible common equity, company-reported (%) | — | — | — | 15.3 |
ROA, total net income / average assets (%) | 0.6 | -2.1 | -1.6 | 1.0 |
ROIC, NOPAT / (debt + preferred + equity) (%) | 4.5 | 8.0 | -4.9 | 6.8 |
Debt / common equity (x) | 0.59 | 0.61 | 0.66 | 0.61 |
Debt / total capital incl. preferred (%) | 31.8 | 32.4 | 33.9 | 33.0 |
Debt / EBIT proxy (x) | 4.9 | 2.9 | — | 4.5 |
Interest coverage, EBIT proxy / interest (x) | 4.8 | 4.5 | -1.9 | 3.2 |
Asset turnover, revenue / average assets (x) | 0.13 | 0.16 | 0.14 | 0.14 |
Gross loss reserves / shareholders' equity (x) | 4.2 | 4.9 | 6.7 | 5.8 |
Net written premium / shareholders' equity (x) | 1.20 | 1.30 | 1.26 | 1.06 |
Income Statement and Margin Analysis (%)
| Metric (USD Mn unless %) | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|
Net income (loss) to common (USD Mn) | 7.6 | 2.8 | -1.0 | 30.1 | -10.9 | 4.4 |
Adjusted net operating income (USD Mn) | 9.1 | 11.7 | 17.4 | 16.0 | 5.8 | 10.0 |
Consolidated combined ratio (%) | 99.5 | 98.6 | 94.0 | 94.1 | 104.6 | 100.2 |
E&S combined ratio (%) | 91.5 | 91.7 | 88.3 | 86.0 | 96.5 | 92.8 |
Net investment income (USD Mn) | 20.0 | 20.5 | 21.9 | 21.0 | 21.3 | 20.3 |
Tangible common equity per share (USD) | — | 7.49 | 8.24 | 8.94 | 8.77 | 9.01 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Region
| Region (GWP, continuing ops, USD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
United States | 1,508.7 | 1,431.8 | 1,172.3 |
Bermuda / International (continuing) | 0 | 0 | 0 |
Region growth (%)
| Region growth (%) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
United States GWP YoY (%) | 6.9 | -5.1 | -18.1 |
Capital Markets
| Measure | Value | Source / basis |
|---|---|---|
Last close | $3.81 (Oct 16, 2026); $3.71 (Oct 15, 2026) | StockTitan |
1-year return | -30.9% (Oct 15, 2025 – Oct 15, 2026) | StockTitan; Boardroom Alpha 1-year TSR -30.5% |
3-year return | Not precisely verified; stock was about $20 in mid-2023 versus $3.81 now (decline of more than 75%) | Dividend-record price points |
5-year return | -87.7% (to Jul 2026) | Arkolith |
52-week range | $3.36 – $7.20 | MarketBeat, Oct 13, 2026 |
Largest single-day move (12 months) | -23.6% (May 5, 2026) | StockTitan |
Share Price
| Metric | Jun 2022 | Dec 2022 | Jun 2023 | Sep 2024 | Jun 2025 | Sep 2025 | Jun 2026 | Oct 2026 |
|---|---|---|---|---|---|---|---|---|
JRVR share price near ex-dividend date (USD) | 25.00 | 22.39 | 20.19 | 7.63 | 4.66 | 5.72 | 4.15 | 3.71 |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
Market capitalization (USD Mn) | 176 | 46.24M shares |
Price / book value | 0.34x | BVPS $11.30 (Jun 30, 2026) |
Price / tangible common equity | 0.42x | TCE per share $9.01 |
P/E, FY2025 diluted EPS | 4.8x | $0.79 |
P/E, trailing 12 months (Q3 2025 – Q2 2026) | ≈ 7.8x | TTM net income to common ≈ $22.7M (≈ $0.49/share) |
P / adjusted operating earnings, TTM | ≈ 3.6x | TTM adjusted net operating income ≈ $49.2M (basic) |
Enterprise value (USD Mn) | ≈ 443 | Market cap 176 + debt 329.9 + preferred 133.1 − cash 195.6 |
EV / revenue, TTM | ≈ 0.68x | TTM revenue ≈ $653.2M |
Dividend yield | ≈ 1.0% | $0.04 annualized |
Dividends & Capital Returns (USD)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividends per common share (USD) | 1.20 | 0.20 | 0.20 | 0.16 | 0.04 |
Credit Ratings
| Agency | Entity | Rating | Outlook | Date |
|---|---|---|---|---|
AM Best | James River Insurance Co.; James River Casualty Co.; Falls Lake National; Stonewood; Falls Lake Fire & Casualty | FSR A- (Excellent); ICR a- | Negative | Affirmed Mar 6, 2026 |
AM Best | James River Group Holdings, Inc. (holding company) | ICR bbb- (Good) | Negative | Affirmed Mar 6, 2026 |
S&P / Moody's / Fitch | — | No public rating identified | — | — |
Capital Instruments
| Instrument | Amount (USD Mn, Jun 30, 2026) | Terms / maturity |
|---|---|---|
Senior debt (bank credit facility) | 225.8 | Net $25M drawn in 2025. A rating downgrade could trigger default (risk factors) |
Junior subordinated debentures (trust preferred) | 104.1 | Issued via James River Capital Trusts I–IV and Franklin Holdings II (Bermuda) Capital Trust I; long-dated (2030s per prior 10-Ks; verify) |
Series A redeemable convertible preferred | 133.1 carrying value (112.5 liquidation preference) | 7% fixed for five years after Sep 30, 2024, then 5-year Treasury + 5.2% capped at 8%; converts into 13,521,634 common shares (implied ≈ $8.32/share) |
Analyst Conclusions
Management guidance
There is no formal numeric guidance. Management's stated priorities are:
-
cautious risk selection, expense management, and operating efficiency enabled by innovation;
-
disciplined deployment of capital in a "competitive E&S backdrop" (CEO, Q2 2026);
-
continued reduction of Specialty Admitted fronting;
-
an effective tax rate approaching the U.S. statutory rate after the redomicile;
-
per the CFO (Q2 2026 call), the residual Specialty Admitted business now contributes mainly through investment income rather than underwriting.
Consensus growth expectations: not publicly available in sources reviewed. The sell-side "Reduce" consensus and declining price targets imply muted expectations.
Bull case
-
Core book is now profitable and stable. The E&S accident-year loss ratio has held at about 63–65% for two years. The E&S combined ratio was 89.4% (FY2025) and 92.8% (Q2 2026), and FY2025 adjusted operating ROTCE was 15.3%. If recent accident years hold, normalized earnings of about $1.00 per share in adjusted operating terms set against a $3.81 share price imply significant upside.
-
Deep discount to tangible book. At 0.42x a $9.01 TCE per share, before counting the $107.8M deferred retroactive gain embedded in tangible equity, the market prices in substantial further reserve losses. The stock has a margin of safety if Q2 2026's de minimis $0.6M adverse development persists.
-
Strategic optionality. Gallatin Point (12.7% common plus preferred, effectively about 32% beneficial) and Enstar (5.6%) are sophisticated insurance investors. The Delaware domicile, the fronting run-off and a cleaned-up structure make JRVR more transactable. The pending Fleming damages claim offers a free option on a recovery.
Bear case
-
Legacy protection is exhausted. The Top Up ADC's last $7.5M was used in Q2 2026. Further adverse development on 2010–2023 E&S casualty, which recurred in Q4 2023, 2024 and Q3 2025 ($51.3M), now hits equity net. A $50M net charge would erase about 12% of tangible common equity.
-
Shrinking, sub-scale, high-cost platform in a softening market. GWP fell 29% in Q2 2026 and NWP 16%. The expense ratio has risen to 33.9%, and rate change has slowed to about 3%. Peers (Kinsale at 75.9%, RLI at 83.6%, Skyward at 89.3%) out-earn JRVR by 7–20 combined-ratio points while growing, so JRVR risks adverse selection.
-
Ratings and governance fragility. AM Best has kept a negative outlook for nearly three years and explicitly cites execution risk on capitalization and leverage. A downgrade to B++ would impair E&S placement and could trigger a credit-facility default. Board turnover (three directors in 2026) and weak say-on-pay support add uncertainty.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
| 2026 annual meeting | Oct 22, 2026 | Say-on-pay result versus 63.4% in 2025; director votes |
| Q3 2026 results (annual E&S detailed valuation review) | Early Nov 2026 (historically Q3) | Net adverse development now unprotected by the ADCs; E&S accident-year loss ratio |
| AM Best annual review | ~Q1 2027 | Outlook revision (stable versus downgrade) |
| Q4 2026 / FY2026 results | ~Mar 2027 | Full-year combined ratio; TCE per share; reserve adequacy commentary |
| Fleming direct-damages litigation | Ongoing | Trial or settlement; potential recovery |
| E&S premium trajectory | Quarterly | Net written premium stabilization; excess casualty growth under the new leader |
| Expense ratio | Quarterly | Path back below 30% as fronting run-off completes |
| Reinsurance renewals | Mid-2027 | Retention, ceding terms, reinstatement provisions |
| Capital actions | Any time | Preferred conversion or redemption; strategic transaction (unconfirmed) |
Analyst verdict
James River has completed the hard structural work of its turnaround. It exited Bermuda reinsurance, ring-fenced 2010–2023 E&S reserves with more than $1.2B of combined retroactive limit, cut fronting exposure and G&A, and redomesticated to Delaware. The result is a much simpler U.S. E&S casualty carrier whose current underwriting is credible: an accident-year loss ratio near 64% and E&S combined ratios of 86–93% in the last four quarters, excluding the reinstatement-affected Q1 2026.
The investment case, however, rests almost entirely on reserves. The adverse development cover that sat above the State National LPT/ADC is now exhausted. The company's own history shows that 2015–2022 casualty years have repeatedly developed adversely, as recently as Q3 2025 ($51.3M). From here, every dollar of legacy deterioration falls directly on a $417M tangible common equity base. That base is already leveraged by a $133M preferred, $330M of debt and $214M of goodwill. The AM Best negative outlook, a sell-side consensus of "Reduce," three 2026 board departures and a weakening E&S pricing environment all argue against assuming a clean outcome.
At roughly 0.4x tangible book and under 4x trailing adjusted operating earnings, the market is discounting meaningful further charges. If recent-year reserves prove adequate and Q3 2026's annual reserve review is benign, the shares could re-rate sharply toward 0.7–0.8x tangible book. Strategic interest from Gallatin Point, Enstar or a third party is a plausible but unconfirmed accelerant.
On balance, JRVR is a high-risk, event-driven special situation rather than a quality compounder. The next two data points, the Q3 2026 reserve review and AM Best's 2027 rating action, should largely determine whether the discount closes or widens.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Age | In role since | Prior roles | Education |
|---|---|---|---|---|---|
Frank N. D'Orazio | Chief Executive Officer; Director | 57 | Nov 2020 | Allied World: Corporate COO and Chief of Staff (2019–2020); President, Underwriting and Global Risk (2014–2019); President, Bermuda and International Insurance (2009–2014). Munich-American Re (1994–2003); Chubb excess casualty (1990–1994) | B.A., Fairfield University |
Sarah C. Doran | Chief Financial Officer | 52 | Jan 2017 | SVP Strategy, IR and Treasurer, Allied World (2013–2016); investment banking (Barclays, Lehman Brothers FIG); LaSalle Investment Management | MBA, University of Chicago; B.A., Notre Dame |
Michael J. Hoffmann | SVP, Group Chief Underwriting Officer | 60 | Nov 2021 | Head of Risk and Ceded Reinsurance, Everest (2020–2021); Global Insurance CUO, Allied World (15 years); Chubb (14 years) | B.A., Swarthmore College |
Jeanette L. Miller | Chief Legal Officer | 46 | Apr 2021 (company since Oct 2018) | International Farming Corp.; CIFC LLC; Milbank LLP | B.S., University of Maine; J.D., Columbia Law School |
Todd R. Sutherland | President, E&S segment | 56 | May 2025 (joined Apr 2023) | Head of U.S. Central Zone, AXA XL; SVP Management Liability, Allied World (13 years); Axis, Kemper, AIG | B.S., Miami University (Ohio) |
Directors' Remuneration
| NEO | 2025 base salary (USD) | 2025 STI paid (USD) | 2025 LTI grant at target (USD) | Other notes |
|---|---|---|---|---|
Frank N. D'Orazio (CEO) | 995,624 | 934,891 | 966,626 | Summary Compensation Table total ≈ $2.93M (salary $991K; non-equity incentive $935K; stock $967K; all other $38K), up ~8% YoY per proxy summary. 2022 total $3,121,935 (2023 proxy); CEO pay ratio 34:1 (2022) |
Sarah C. Doran (CFO) | 589,160 | 553,221 | 572,000 | Second 50% of $572,000 retention award paid Jun 2025 |
Richard J. Schmitzer (former E&S CEO) | 463,479 | 421,869 | 669,954 | Retired Oct 15, 2025; retention award $669,955 (50% paid 2025) |
Michael J. Hoffmann (Group CUO) | 455,260 | 320,617 | 442,000 | Retention award $331,500 (50% paid 2025) |
Jeanette L. Miller (CLO) | 370,800 | 261,136 | 270,000 | Retention award $270,000 (50% paid 2025) |
Todd R. Sutherland (E&S President) | 375,119 | 295,620 | 250,000 (off-cycle RSUs) | Cash LTIP awards of $156,000 (2024) and $160,680 (2025) |
Board of Directors
| Director | Age | Since | Role / independence | Background | 2026 status |
|---|---|---|---|---|---|
Christine LaSala | 75 | Jul 2024 | Non-Executive Chair (since Feb 2025); independent | Former Chair, WTW North America; CEO, WTC Captive; President, Johnson & Higgins NY; ex-Beazley plc board; Sedgwick board | Nominee |
Frank N. D'Orazio | 57 | 2020 | CEO; not independent | See above | Nominee |
Matthew B. Botein | 53 | Jan 2023 | Gallatin Point designee; independence status per proxy | Co-founder and Managing Partner, Gallatin Point; ex-BlackRock Alternative Investors CIO; boards include Bowhead Specialty, Canopius parent | Nominee |
Joel D. Cavaness | 65 | Jul 2025 | Independent | Co-founder and President, Risk Placement Services (Gallagher); WSIA board 2010–2022 | Nominee |
Peter B. Migliorato | 66 | Oct 2022 | Independent | Retired Deloitte Consulting insurance partner; insurtech advisor (Owl.co, Machine Cover, Aniline) | Nominee |
Rajiv Basu | — | Jun 8, 2026 | Independent; Audit Committee Chair | ~40 years at Deloitte & Touche (insurance audit); Assurant board | Nominee |
Thomas L. Brown | 69 | Oct 2021 | Independent; audit committee financial expert | Former CFO, RLI Corp.; ex-PwC partner | Not standing (notified Aug 31, 2026) |
Kirstin M. Gould | 59 | Oct 2021 | Independent | Former EVP and General Counsel, XL Group | Resigned Aug 20, 2026 |
Dennis J. Langwell | 67 | Apr 2023 | Former Audit Chair; independent | Former Vice Chairman and CFO, Liberty Mutual | Resigned effective Jun 16, 2026 |
Major Shareholders
| Holder | Shares | % of 46.24M common | As of / source |
|---|---|---|---|
Gallatin Point Capital (GPC Partners Investments (Thames) LP) | 5,859,375 common, plus Series A convertible into 13,521,634 | 12.7% of common; ≈32.4% beneficial including conversion (proxy summary) | 13F Jun 30, 2026; DEF 14A 2026 |
Zimmer Partners LP | 4,623,685 | 10.0% | 13F Jun 30, 2026 |
T. Rowe Price Investment Management | 4,605,838 | 10.0% | 13F Jun 30, 2026 |
BlackRock, Inc. | 3,394,851 | 7.3% | 13F Jun 30, 2026 |
Enstar Group / Cavello Bay Reinsurance | 2,590,765 | 5.6% | 13G/A; DEF 14A (Sep 1, 2026) |
Continental General Insurance Co. | 2,520,242 | 5.5% | 13F Mar 31, 2026 |
Donald Smith & Co. | 2,440,347 | 5.3% (13G: 5.28%) | 13F Jun 30, 2026 |
Vanguard Group | 2,264,383 | 4.9% | 13F Dec 31, 2025 |
Vanguard Capital Management | 1,724,161 | 3.7% | 13F Jun 30, 2026 |
RBF Capital | 1,128,525 | 2.4% | 13F Mar 31, 2026 |
Competitive Landscape
Peer Comparison FY2025
| Metric | James River (JRVR) | Kinsale (KNSL) | RLI Corp. (RLI) | Skyward (SKWD) | Bowhead (BOW) |
|---|---|---|---|---|---|
Gross written premium (USD Mn) | 1,172.3 | 1,977.2 | 2,026.8 | 2,166.2 | 862.8 |
GWP growth YoY (%) | -18.1 | 5.7 | 1.0 | 24.3 | 24.0 |
Total revenue (USD Mn) | 687.6 | ≈1900 | 1,882.4 | — | — |
Combined ratio (%) | 96.6 | 75.9 | 83.6 | 89.3 | 96.5 |
Return metric (%) | 7.9 (GAAP ROE); 15.3 (adj. op. ROTCE) | 26.4 (operating ROE) | — | 18.9 (ROE) | — |



